Why 5 Billionaires are Buying this $4 Stock 🔥

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Monday! Today is October 17th. Let's get ready to trade! Markets 📈 The S&P 500 tumbled 2.3% on Friday despite opening the session higher. The Nasdaq fared even worse with a 3.0% decline, and the Dow lost 1.3% on the trading day. The small-cap Russell 2K fell 2.6%. Today, futures are on the rise in early-morning trading. S&P 500 contracts are currently showing a 1.1% gain. Sponsored [Why 5 Billionaires are Buying this $4 Stock]( 🔥 Bill Gates, Jack Ma, Richard Branson, Michael Bloomberg, & Jeff Bezos are all backing a tiny $4 company… And it has the potential to ignite a $130 trillion new energy revolution. [Find out why in the 30-second demonstration.]( Premarket Highlights 🔎 - The UK has canceled nearly all of its recently announced tax plans in the wake of widespread uncertainty surrounding the country's bond market. New UK Treasury Chief Jeremy Hunt is overseeing the effort. - A survey of Economists showed that the majority now believe the US will enter a full-blown recession within the next 12 months, according to a WSJ report. What to Watch Today 👀 Bank Earnings Bank of America reports earnings today, and investors will be listening closely for hints about the bank's outlook for the US economy. Banks tend to be among the first companies to see economic troubles on the horizon, so BOA's earnings report could set the tone for today's trading session. International 🌍 Asia Japan's Nikkei 225 fell 1.1% overnight, while India's BSE Sensex notched a 0.8% advance. The Australian ASX 200 fell 1.4%. Europe Germany's DAX is up 0.7% midway through its trading day, and the Italian FTSE MIB is up 0.8%. The Euro Stoxx 600 is showing a 0.7% gain. Major Earnings 💰 Bank of America [BOA] ... AM Charles Schwab [SCHW] ... AM Bank of NY Mellon [BK] ... AM Equity Lifestyle Properties [ELS] ... PM FB Financial Corp [FBK] ... PM Crossfit Bankshares [CFB] ... PM Economy 🏗 - Empire State Mfg. [Oct] ... 8:30a Running Hot 🔥 Gainers - Agrify Corp [AGFY] >> +25.5% - Fednat Holding [FNHC] >> +32.6% - Archaea Energy [LFG] >> +51.6% Decliners - NuCana PLC [NCNA] >> (27.8%) - Eyenovia [EYEN] >> (11.0%) - Intelligent Living [ILAG] >> (12.9%) Bank of NY Mellon Corp [BK] - Last Close: $38.41 BNY Mellon is trending after an early morning earnings release. The mid-cap bank reported better-than-expected Q3 adjusted earnings of $1.21 per share, up from $1.09 a year earlier, and beat the Street's $1.08 per share target. BNY's total revenues for Q3 came in at $4.28 billion, which also beat analysts' forecast of $4.20 billion. The bank also announced it would maintain its quarterly dividend at $0.37 per share, payable on Nov. 10th to shareholders of record on Oct. 27th. BK is leading the S&P 500 with a 4.8% gain. My Take: Good quarter for BNY Mellon, but the stock has been in a down-trend since August. However, it could be a good value at this price point. Milestone Pharmaceuticals [MIST] - Last Close: $8.49 Breakthrough clinical data is boosting shares of Milestone Pharma. This morning, the micro-cap biopharma firm announced its paroxysmal supraventricular tachycardia therapeutic candidate, etripamil, met its primary endpoint during a Phase 3 trial. The drug candidate demonstrated "statistically substantial" and "clinically meaningful" effects compared to placebo, Milestone said in a statement accompanying the data release. Eetripamil also showed a consistent safety and tolerability profile that may clear the way for patient self-use. Milestone says it plans to file a new drug application with the US Food & Drug Administration by the middle of next year. MIST is up 29.3% on active premarket trading volume. My Take: This drug still has a long way to go before it gets full FDA approval. However, MIST has been on a hot steak since May. This could be a micro-cap biotech stock worth adding to your watchlist. Acorda Therapeutics [ACOR] - Last Close: $0.3353 Acorda Therapeutics is surging on news of a favorable court ruling. The biopharma firm announced Sunday that a three-judge arbitration panel awarded it $16.5 million in a deciding ruling on the company's license dispute with Alkermes [ALKS]. According to the ruling, Acorda will receive $15 million plus prejudgment interest of $1.5 million. Also, Acorda will no longer have to pay Alkermes any royalties on net sales fo the license and supply of the AMPYRA drug, which was the subject of the dispute. "Acorda is now free to use alternative sources for supply of AMPYRA, which the company has already secured," the company said in a statement. ACOR is trading actively with a 57.1% gain on the news. My Take: This tiny stock seems to have found some support at the $0.30 mark, and today's rally could give it an extra push. But, you should expect some volatility in this very low-float stock. Inpixon [INPX] - Last Close: $4.78 Inpixon is skyrocketing in an epic rebound rally. The tiny IT services stock set a new 52-week low last Thursday when shares tumbled as low as $4.26, but share prices began to rebound the next day. INPX shrugged off its new 52-week low with a 9.8% rally on Friday, despite no news reports pertaining to the stock. Today, the rebound rally has kicked into fifth gear. Shares are up big ahead of the opening bell with almost no news to explain the move. INPX is one of this morning's most actively-traded stocks, and it's up 60.8%. My Take: This rally has all the hallmarks of a short squeeze. INPX's short ratio is extremely elevated, and the bulls seem to have zeroed in on this low-float opportunity. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( P.P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! Or Text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](